|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298.19 USD | +1.19% |
|
+2.76% | +24.02% |
| 13/02 | Diary - U.S. earnings week ahead | RE |
| 13/01 | Baird Adjusts Nordson Price Target to $278 From $275, Maintains Neutral Rating | MT |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.19 | 10.95 | 9.39 | 7.49 | 7.69 | |||||
Return on Total Capital | 12.44 | 13.3 | 11.19 | 8.67 | 8.83 | |||||
Return On Equity % | 23.19 | 23.04 | 19.93 | 16.9 | 16.21 | |||||
Return on Common Equity | 23.19 | 23.04 | 19.93 | 16.9 | 16.21 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.05 | 55.07 | 54.23 | 55.25 | 55.27 | |||||
SG&A Margin | 30.28 | 29.33 | 28.3 | 30.19 | 28.99 | |||||
EBITDA Margin % | 30.17 | 29.6 | 30.18 | 30.12 | 31.67 | |||||
EBITA Margin % | 27.91 | 27.71 | 28.2 | 27.92 | 29.11 | |||||
EBIT Margin % | 25.77 | 25.74 | 25.93 | 25.06 | 26.27 | |||||
Income From Continuing Operations Margin % | 19.23 | 19.81 | 18.55 | 17.37 | 17.35 | |||||
Net Income Margin % | 19.23 | 19.81 | 18.55 | 17.37 | 17.35 | |||||
Net Avail. For Common Margin % | 19.23 | 19.81 | 18.55 | 17.37 | 17.35 | |||||
Normalized Net Income Margin | 15.19 | 15.67 | 14.63 | 13.6 | 13.73 | |||||
Levered Free Cash Flow Margin | 20.59 | 15.84 | 14.01 | 13.7 | 19.64 | |||||
Unlevered Free Cash Flow Margin | 21.27 | 16.38 | 15.43 | 15.77 | 21.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.68 | 0.58 | 0.48 | 0.47 | |||||
Fixed Assets Turnover | 4.99 | 5.62 | 5.51 | 4.73 | 4.53 | |||||
Receivables Turnover (Average Receivables) | 5.2 | 5.32 | 5 | 4.85 | 5.01 | |||||
Inventory Turnover (Average Inventory) | 3.44 | 3.28 | 2.87 | 2.58 | 2.71 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.62 | 1.36 | 2.11 | 2.41 | 1.64 | |||||
Quick Ratio | 1.76 | 0.83 | 1.21 | 1.34 | 0.91 | |||||
Operating Cash Flow to Current Liabilities | 1.23 | 0.62 | 1.1 | 1.05 | 0.95 | |||||
Days Sales Outstanding (Average Receivables) | 70.18 | 68.63 | 72.93 | 75.51 | 72.89 | |||||
Days Outstanding Inventory (Average Inventory) | 106.22 | 111.44 | 127.13 | 141.64 | 134.71 | |||||
Average Days Payable Outstanding | 27.27 | 28.57 | 29.44 | 30.47 | 32.83 | |||||
Cash Conversion Cycle (Average Days) | 149.13 | 151.5 | 170.62 | 186.68 | 174.77 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 44.07 | 37.5 | 71.7 | 79.13 | 68.75 | |||||
Total Debt / Total Capital | 30.59 | 27.27 | 41.76 | 44.18 | 40.74 | |||||
LT Debt/Equity | 41.42 | 19.49 | 66.41 | 74.83 | 57.63 | |||||
Long-Term Debt / Total Capital | 28.75 | 14.18 | 38.68 | 41.77 | 34.15 | |||||
Total Liabilities / Total Assets | 43.05 | 39.94 | 50.53 | 51.14 | 48.57 | |||||
EBIT / Interest Expense | 23.88 | 29.75 | 11.45 | 7.58 | 7.04 | |||||
EBITDA / Interest Expense | 28.86 | 35.19 | 13.7 | 9.37 | 8.71 | |||||
(EBITDA - Capex) / Interest Expense | 27.36 | 32.9 | 13.12 | 8.65 | 8.15 | |||||
Total Debt / EBITDA | 1.29 | 1.09 | 2.29 | 2.78 | 2.31 | |||||
Net Debt / EBITDA | 0.89 | 0.88 | 2.14 | 2.65 | 2.19 | |||||
Total Debt / (EBITDA - Capex) | 1.36 | 1.17 | 2.39 | 3.02 | 2.46 | |||||
Net Debt / (EBITDA - Capex) | 0.93 | 0.95 | 2.24 | 2.87 | 2.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.37 | 9.65 | 1.48 | 2.33 | 3.78 | |||||
Gross Profit, 1 Yr. Growth % | 17.13 | 7.74 | -0.08 | 4.26 | 3.29 | |||||
EBITDA, 1 Yr. Growth % | 31.93 | 7.59 | 3.47 | 3.25 | 7.26 | |||||
EBITA, 1 Yr. Growth % | 36.27 | 8.85 | 3.28 | 2.52 | 6.24 | |||||
EBIT, 1 Yr. Growth % | 42.61 | 9.54 | 2.2 | 0.18 | 6.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 82.08 | 12.93 | -4.99 | -4.15 | 3.68 | |||||
Net Income, 1 Yr. Growth % | 82.08 | 12.93 | -4.99 | -4.15 | 3.68 | |||||
Normalized Net Income, 1 Yr. Growth % | 47.66 | 13.08 | -5.23 | -4.85 | 3.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 81.26 | 13.82 | -3.97 | -4.14 | 4.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.19 | 6.36 | 9.22 | 2.41 | -1.48 | |||||
Inventory, 1 Yr. Growth % | 18.11 | 17.18 | 18.62 | 4.87 | -6.73 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.98 | -2.29 | 9.5 | 27.9 | -6.87 | |||||
Total Assets, 1 Yr. Growth % | 3.16 | 0.78 | 37.47 | 14.27 | -1.39 | |||||
Tangible Book Value, 1 Yr. Growth % | -124.48 | 80.87 | -635.87 | 26.85 | -13.47 | |||||
Common Equity, 1 Yr. Growth % | 22.75 | 6.26 | 13.24 | 12.86 | 3.8 | |||||
Cash From Operations, 1 Yr. Growth % | 8.66 | -6.01 | 24.97 | -13.27 | 29.3 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.21 | 34.27 | -32.75 | 86.25 | -9.86 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 31.92 | -15.67 | -10.22 | 1.57 | 45.33 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 29.2 | -15.55 | -4.42 | 6.02 | 41.7 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.8 | 29.76 | 20.64 | 7.22 | 12.06 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.76 | 10.51 | 5.49 | 1.91 | 3.05 | |||||
Gross Profit, 2 Yr. CAGR % | 5.39 | 12.33 | 3.76 | 2.07 | 3.72 | |||||
EBITDA, 2 Yr. CAGR % | 9.92 | 19.14 | 5.51 | 3.05 | 4.97 | |||||
EBITA, 2 Yr. CAGR % | 11.08 | 21.79 | 6.03 | 2.57 | 4.09 | |||||
EBIT, 2 Yr. CAGR % | 12.67 | 24.99 | 5.8 | 0.83 | 3.08 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 16.1 | 43.39 | 3.58 | -4.57 | -0.31 | |||||
Net Income, 2 Yr. CAGR % | 16.1 | 43.39 | 3.58 | -4.57 | -0.31 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.41 | 29.22 | 3.52 | -5.04 | -0.87 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.62 | 43.64 | 4.55 | -4.06 | 0.3 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.5 | 7.27 | 7.78 | 5.76 | 0.45 | |||||
Inventory, 2 Yr. CAGR % | 7.45 | 17.64 | 17.89 | 11.53 | -1.1 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.13 | -2.64 | 3.44 | 18.34 | 9.14 | |||||
Total Assets, 2 Yr. CAGR % | 3.83 | 1.96 | 17.7 | 25.33 | 6.15 | |||||
Tangible Book Value, 2 Yr. CAGR % | -57 | -33.46 | 211.32 | 160.72 | 4.77 | |||||
Common Equity, 2 Yr. CAGR % | 16.86 | 14.21 | 9.69 | 13.05 | 8.23 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.41 | 1.06 | 8.38 | 4.11 | 5.9 | |||||
Capital Expenditures, 2 Yr. CAGR % | -22.79 | 0.88 | -4.98 | 11.91 | 29.57 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 39.67 | 5.48 | -12.99 | -4.94 | 21.1 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 34.23 | 4.45 | -10.16 | 0.27 | 22.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.39 | 19.37 | 25.12 | 13.74 | 9.61 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.57 | 5.69 | 7.41 | 4.43 | 2.53 | |||||
Gross Profit, 3 Yr. CAGR % | 2.31 | 6.17 | 8.03 | 3.92 | 2.65 | |||||
EBITDA, 3 Yr. CAGR % | 5.52 | 9.14 | 13.67 | 4.37 | 5.04 | |||||
EBITA, 3 Yr. CAGR % | 6 | 10.33 | 15.28 | 4.43 | 4.42 | |||||
EBIT, 3 Yr. CAGR % | 6.92 | 11.62 | 16.88 | 3.45 | 3.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.38 | 15.03 | 25.01 | 0.94 | -1.9 | |||||
Net Income, 3 Yr. CAGR % | 6.38 | 15.03 | 25.01 | 0.94 | -1.9 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.78 | 14.63 | 16.53 | 0.65 | -1.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.54 | 15.02 | 25.6 | 1.57 | -1.15 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.43 | 0.37 | 7.92 | 5.96 | 3.29 | |||||
Inventory, 3 Yr. CAGR % | 7.35 | 10.6 | 17.97 | 13.38 | 5.08 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.45 | 4.54 | 1.25 | 11.02 | 9.26 | |||||
Total Assets, 3 Yr. CAGR % | 3.48 | 2.8 | 12.64 | 16.54 | 15.7 | |||||
Tangible Book Value, 3 Yr. CAGR % | -48.72 | -30.59 | 33.38 | 130.8 | 80.51 | |||||
Common Equity, 3 Yr. CAGR % | 14.17 | 13.22 | 13.88 | 10.74 | 9.88 | |||||
Cash From Operations, 3 Yr. CAGR % | 2.66 | 10.25 | 8.47 | 0.62 | 11.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | -24.72 | -7.15 | -11.88 | 18.92 | 4.13 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.72 | 18.05 | -0.04 | -8.84 | 10.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.57 | 15.01 | 1.41 | -5.49 | 13.29 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.36 | 15.09 | 19.79 | 18.84 | 13.17 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.48 | 4.62 | 3.12 | 4.16 | 5.65 | |||||
Gross Profit, 5 Yr. CAGR % | 5.91 | 4.6 | 2.89 | 4.51 | 6.42 | |||||
EBITDA, 5 Yr. CAGR % | 8.7 | 6.93 | 5.52 | 6.55 | 10.35 | |||||
EBITA, 5 Yr. CAGR % | 9.01 | 7.38 | 6.01 | 7.04 | 10.93 | |||||
EBIT, 5 Yr. CAGR % | 8.81 | 7.82 | 6.47 | 7.04 | 11.43 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.82 | 11.65 | 5.25 | 6.75 | 14.19 | |||||
Net Income, 5 Yr. CAGR % | 10.82 | 11.65 | 5.25 | 6.75 | 14.19 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.69 | 9.09 | 6.65 | 6.31 | 9.54 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.35 | 11.64 | 5.74 | 6.97 | 14.79 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.87 | 0.84 | 3.31 | 2.49 | 4.87 | |||||
Inventory, 5 Yr. CAGR % | 8.23 | 7.73 | 11.45 | 10.97 | 9.93 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.3 | 5.64 | 5.23 | 9.86 | 4.34 | |||||
Total Assets, 5 Yr. CAGR % | 9.39 | 2.27 | 8.95 | 11.28 | 10 | |||||
Tangible Book Value, 5 Yr. CAGR % | -29.69 | -30.39 | 5.5 | 17.85 | 21.1 | |||||
Common Equity, 5 Yr. CAGR % | 20.45 | 14.7 | 12.36 | 13.15 | 11.59 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.28 | 7.54 | 4.91 | 7.75 | 7.44 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.84 | -6.39 | -17.37 | 0.05 | 2.82 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.34 | 14.05 | 2.17 | 8.12 | 8.26 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.99 | 12.5 | 2.31 | 8.75 | 9.55 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.16 | 14.45 | 16.04 | 14.55 | 15.61 |
- Stock Market
- Equities
- NDSN Stock
- Financials Nordson Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















